Cargando…

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value

In recent years, major discoveries have indicated that Ras homology family member C (RHOC) is involved in the occurrence and pathological progression of a number of malignant tumours; nevertheless, the role served by RHOC in glioma remains unclear. The present study aimed to gain further insight int...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Yao, Jiawei, Lian, Xiaoyu, Liu, Binfeng, Wang, Yanbiao, Wang, Hongbo, Wang, Jialin, Zhang, Mengjun, Zhao, Yaoye, Zhu, Yongjie, Liu, Runze, Gao, Yanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278397/
https://www.ncbi.nlm.nih.gov/pubmed/34276990
http://dx.doi.org/10.3892/mco.2021.2333
_version_ 1783722251509563392
author Zhang, Bo
Yao, Jiawei
Lian, Xiaoyu
Liu, Binfeng
Wang, Yanbiao
Wang, Hongbo
Wang, Jialin
Zhang, Mengjun
Zhao, Yaoye
Zhu, Yongjie
Liu, Runze
Gao, Yanzheng
author_facet Zhang, Bo
Yao, Jiawei
Lian, Xiaoyu
Liu, Binfeng
Wang, Yanbiao
Wang, Hongbo
Wang, Jialin
Zhang, Mengjun
Zhao, Yaoye
Zhu, Yongjie
Liu, Runze
Gao, Yanzheng
author_sort Zhang, Bo
collection PubMed
description In recent years, major discoveries have indicated that Ras homology family member C (RHOC) is involved in the occurrence and pathological progression of a number of malignant tumours; nevertheless, the role served by RHOC in glioma remains unclear. The present study aimed to gain further insight into the biological function and expression of RHOC in human glioma based on the Chinese Glioma Genome Atlas (CGGA). The current study analysed ~1,000 glioma samples from the CGGA. First, RHOC expression was analysed according to the clinical features associated with the prognosis of glioma, such as clinical stage, histological type and age. Second, the Kaplan-Meier method was used, revealing that the survival rate of patients with glioma with high RHOC expression was significantly lower than that of patients with low RHOC expression. Receiver operating characteristic curve analysis indicated that RHOC had moderate diagnostic value for patients with glioma. Gene set enrichment analysis indirectly indicated that RHOC mainly participated in the pathological mechanism of glioma through p53, extracellular matrix receptor interaction and focal adhesion. Finally, the aforementioned results were further verified using The Cancer Genome Atlas data and reverse transcription-quantitative PCR technology. To the best of our knowledge, the present study was the first comprehensive in-depth analysis of RHOC, revealing the potential value of RHOC as a novel oncogene in glioma. The current study provided a novel potential biomarker for the diagnosis and prognosis of glioma, and re-examined the pathological mechanism of glioma from a new perspective.
format Online
Article
Text
id pubmed-8278397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-82783972021-07-15 Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value Zhang, Bo Yao, Jiawei Lian, Xiaoyu Liu, Binfeng Wang, Yanbiao Wang, Hongbo Wang, Jialin Zhang, Mengjun Zhao, Yaoye Zhu, Yongjie Liu, Runze Gao, Yanzheng Mol Clin Oncol Articles In recent years, major discoveries have indicated that Ras homology family member C (RHOC) is involved in the occurrence and pathological progression of a number of malignant tumours; nevertheless, the role served by RHOC in glioma remains unclear. The present study aimed to gain further insight into the biological function and expression of RHOC in human glioma based on the Chinese Glioma Genome Atlas (CGGA). The current study analysed ~1,000 glioma samples from the CGGA. First, RHOC expression was analysed according to the clinical features associated with the prognosis of glioma, such as clinical stage, histological type and age. Second, the Kaplan-Meier method was used, revealing that the survival rate of patients with glioma with high RHOC expression was significantly lower than that of patients with low RHOC expression. Receiver operating characteristic curve analysis indicated that RHOC had moderate diagnostic value for patients with glioma. Gene set enrichment analysis indirectly indicated that RHOC mainly participated in the pathological mechanism of glioma through p53, extracellular matrix receptor interaction and focal adhesion. Finally, the aforementioned results were further verified using The Cancer Genome Atlas data and reverse transcription-quantitative PCR technology. To the best of our knowledge, the present study was the first comprehensive in-depth analysis of RHOC, revealing the potential value of RHOC as a novel oncogene in glioma. The current study provided a novel potential biomarker for the diagnosis and prognosis of glioma, and re-examined the pathological mechanism of glioma from a new perspective. D.A. Spandidos 2021-09 2021-06-29 /pmc/articles/PMC8278397/ /pubmed/34276990 http://dx.doi.org/10.3892/mco.2021.2333 Text en Copyright: © Zhang et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Bo
Yao, Jiawei
Lian, Xiaoyu
Liu, Binfeng
Wang, Yanbiao
Wang, Hongbo
Wang, Jialin
Zhang, Mengjun
Zhao, Yaoye
Zhu, Yongjie
Liu, Runze
Gao, Yanzheng
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title_full Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title_fullStr Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title_full_unstemmed Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title_short Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
title_sort role of rhoc in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278397/
https://www.ncbi.nlm.nih.gov/pubmed/34276990
http://dx.doi.org/10.3892/mco.2021.2333
work_keys_str_mv AT zhangbo roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT yaojiawei roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT lianxiaoyu roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT liubinfeng roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT wangyanbiao roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT wanghongbo roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT wangjialin roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT zhangmengjun roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT zhaoyaoye roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT zhuyongjie roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT liurunze roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue
AT gaoyanzheng roleofrhocinevaluatinganadverseprognosisinpatientswithgliomaanditspotentialprognosticvalue